Isomorphic Labs is reimagining the entire drug discovery process from first principles with an AI-first approach.

Sector

Life Sciences

Date Invested

2025

Investor

Krishna Yeshwant (left)

First Round

Series A

Founder & CEO

Sir Demis Hassabis, PhD (right)